Definition · Plain-language
Serious adverse event (SAE)
A serious adverse event (SAE) is an adverse event that meets one of the specific seriousness criteria defined in ICH E2A, marking it out for expedited regulatory attention.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
The ICH E2A seriousness criteria
Under the international ICH E2A standard, an adverse event or reaction is classified as serious if it meets at least one of a defined set of criteria: it results in death; is life-threatening; requires inpatient hospitalisation or prolongs an existing hospitalisation; results in persistent or significant disability or incapacity; results in a congenital anomaly or birth defect; or is another medically important condition that, in the judgement of the reporter, may jeopardise the patient or require intervention to prevent one of the listed outcomes. Meeting any single criterion makes the event serious.
Serious is not the same as severe
A common point of confusion is the difference between "serious" and "severe". Severity describes the intensity of an event — a headache might be mild, moderate or severe — whereas seriousness is a regulatory classification based strictly on the E2A outcome criteria. A severe headache that does not meet any seriousness criterion is not a serious adverse event, while a relatively mild event that leads to hospitalisation is. Keeping the two concepts separate is essential for correct safety classification and reporting.
Why the classification matters
The serious classification drives regulatory reporting obligations. Serious adverse events — particularly those that are unexpected and suspected to be related to an investigational product — trigger expedited reporting to regulators and ethics committees within defined timeframes, so that emerging risks can be acted on quickly. Accurate, consistent application of the E2A criteria therefore underpins the timeliness of pharmacovigilance. The same definition is used to structure comparisons between serious and non-serious events across regulatory systems.
Key facts
At a glance
- Definition: An adverse event meeting at least one ICH E2A seriousness criterion.
- Stands for: Serious adverse event (SAE).
- Criteria: Death; life-threatening; hospitalisation; disability; congenital anomaly; other medically important event.
- Source: ICH E2A definition.
- Distinction: Seriousness is not the same as severity.
- Consequence: Drives expedited safety reporting timelines.
Common misconceptions
What people often get wrong
Often heard: A serious adverse event just means a very severe or painful one.
Actually: Seriousness is defined by the ICH E2A outcome criteria — death, life-threatening, hospitalisation, disability, congenital anomaly or another medically important event — not by how severe the symptom is.
Often heard: An event must meet several criteria to count as serious.
Actually: Meeting any single one of the E2A criteria is enough for an event to be classified as serious.
Often heard: A serious adverse event proves the medicine caused harm.
Actually: Seriousness classifies the outcome, not the cause. Causality between the product and the event is assessed separately from whether the event is serious.
Going deeper
